Global Gene Cell Therapy CDMO Market Research Report 2026(Status and Outlook)
Gene Cell Therapy CDMO provides end-to-end customized R&D and manufacturing services for advanced therapies such as gene therapy and cell therapy, from process development to production scale-up. Their core strength lies in addressing the extreme complexity of using live cells or viral vectors as "drugs," encompassing vector design and construction, cell collection and modification, process development and optimization, rigorous quality control and release testing, and clinical- and commercial-grade aseptic manufacturing. This field has extremely high barriers to entry, requiring companies to possess cutting-edge biological technologies, GMP-compliant closed-loop automated production systems, and the expertise to meet stringent global regulations. They are indispensable industrialization partners for pharmaceutical companies to bring cutting-edge therapies from the laboratory to market.Gene Cell Therapy CDMO has a highly complex cost structure, primarily including cutting-edge R&D and highly skilled human resources costs, customized GMP facilities and expensive one-time production consumables, as well as stringent quality control and testing fees. Their gross profit margins range widely (typically 30%-60% or higher), depending mainly on the uniqueness of the technology platform, process efficiency, and capacity utilization. Early highly personalized therapies face significant cost pressures due to limited scale, while mature, large-scale platform-based manufacturing (such as allogeneic therapies and viral vectors) can achieve higher profitability through standardization and capacity expansion.The global landscape of Gene Cell Therapy CDMO is characterized by "technology leadership, regional concentration, and multi-point breakthroughs." North America remains the absolute innovation center and largest source of demand globally, boasting the most mature capital markets, top biotech companies, and leading CDMO firms, dominating technology and standard development. Europe follows closely behind, possessing strong capabilities in specific technological routes and clinical translation thanks to its deep research foundation and rigorous regulatory system. The Asia-Pacific region, especially China, is becoming the fastest-growing market globally, driven by strong policy support, the rise of domestic innovative pharmaceutical companies, and huge clinical demand. It is rapidly moving from early technology imports to independent innovation and internationalization, with South Korea and Japan also actively expanding their presence. Currently, supply chain stability, geopolitical factors, and the need for proximity to clinical centers are driving the global production capacity layout towards regionalization and diversification.
The global Gene Cell Therapy CDMO market size was estimated at USD 2320.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Cell Therapy CDMO market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Cell Therapy CDMO market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Cell Therapy CDMO market.
Global Gene Cell Therapy CDMO Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Catalent
Lonza
Charles River
Oxford Biomedica
Novartis
OBiO
GenScript
Pharmaron
Porton
Resilience
SK Pharmteco
Forge Biologics
Andelyn Biosciences
Roslin CT
eXmoor Pharma
Advanced Therapies
Catalent Biologics
Patheon Pharma Services
Market Segmentation (by Type)
Immune Cells
Stem Cell
Viral Vector
Plasmid DNA
Market Segmentation (by Application)
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Cell Therapy CDMO Market
Overview of the regional outlook of the Gene Cell Therapy CDMO Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Cell Therapy CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Cell Therapy CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Gene Cell Therapy CDMO market size was estimated at USD 2320.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Cell Therapy CDMO market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Cell Therapy CDMO market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Cell Therapy CDMO market.
Global Gene Cell Therapy CDMO Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Catalent
Lonza
Charles River
Oxford Biomedica
Novartis
OBiO
GenScript
Pharmaron
Porton
Resilience
SK Pharmteco
Forge Biologics
Andelyn Biosciences
Roslin CT
eXmoor Pharma
Advanced Therapies
Catalent Biologics
Patheon Pharma Services
Market Segmentation (by Type)
Immune Cells
Stem Cell
Viral Vector
Plasmid DNA
Market Segmentation (by Application)
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Cell Therapy CDMO Market
Overview of the regional outlook of the Gene Cell Therapy CDMO Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Cell Therapy CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Cell Therapy CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gene Cell Therapy CDMO
1.2 Key Market Segments
1.2.1 Gene Cell Therapy CDMO Segment by Type
1.2.2 Gene Cell Therapy CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE CELL THERAPY CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE CELL THERAPY CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Cell Therapy CDMO Product Life Cycle
3.3 Global Gene Cell Therapy CDMO Revenue Market Share by Company (2020-2025)
3.4 Gene Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Gene Cell Therapy CDMO Market Competitive Situation and Trends
3.6.1 Gene Cell Therapy CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene Cell Therapy CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GENE CELL THERAPY CDMO VALUE CHAIN ANALYSIS
4.1 Gene Cell Therapy CDMO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE CELL THERAPY CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Cell Therapy CDMO Market Porter's Five Forces Analysis
6 GENE CELL THERAPY CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Cell Therapy CDMO Market by Type (2020-2025)
6.3 Global Gene Cell Therapy CDMO Market Size Growth Rate by Type (2021-2025)
7 GENE CELL THERAPY CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Cell Therapy CDMO Market Size (M USD) by Application (2020-2025)
7.3 Global Gene Cell Therapy CDMO Market Size Growth Rate by Application (2021-2025)
8 GENE CELL THERAPY CDMO MARKET SEGMENTATION BY REGION
8.1 Global Gene Cell Therapy CDMO Market Size by Region
8.1.1 Global Gene Cell Therapy CDMO Market Size by Region
8.1.2 Global Gene Cell Therapy CDMO Market Size Market Share by Region
8.2 North America
8.2.1 North America Gene Cell Therapy CDMO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene Cell Therapy CDMO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Gene Cell Therapy CDMO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene Cell Therapy CDMO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene Cell Therapy CDMO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Catalent
9.1.1 Catalent Basic Information
9.1.2 Catalent Gene Cell Therapy CDMO Product Overview
9.1.3 Catalent Gene Cell Therapy CDMO Product Market Performance
9.1.4 Catalent SWOT Analysis
9.1.5 Catalent Business Overview
9.1.6 Catalent Recent Developments
9.2 Lonza
9.2.1 Lonza Basic Information
9.2.2 Lonza Gene Cell Therapy CDMO Product Overview
9.2.3 Lonza Gene Cell Therapy CDMO Product Market Performance
9.2.4 Lonza SWOT Analysis
9.2.5 Lonza Business Overview
9.2.6 Lonza Recent Developments
9.3 Charles River
9.3.1 Charles River Basic Information
9.3.2 Charles River Gene Cell Therapy CDMO Product Overview
9.3.3 Charles River Gene Cell Therapy CDMO Product Market Performance
9.3.4 Charles River SWOT Analysis
9.3.5 Charles River Business Overview
9.3.6 Charles River Recent Developments
9.4 Oxford Biomedica
9.4.1 Oxford Biomedica Basic Information
9.4.2 Oxford Biomedica Gene Cell Therapy CDMO Product Overview
9.4.3 Oxford Biomedica Gene Cell Therapy CDMO Product Market Performance
9.4.4 Oxford Biomedica Business Overview
9.4.5 Oxford Biomedica Recent Developments
9.5 Novartis
9.5.1 Novartis Basic Information
9.5.2 Novartis Gene Cell Therapy CDMO Product Overview
9.5.3 Novartis Gene Cell Therapy CDMO Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 OBiO
9.6.1 OBiO Basic Information
9.6.2 OBiO Gene Cell Therapy CDMO Product Overview
9.6.3 OBiO Gene Cell Therapy CDMO Product Market Performance
9.6.4 OBiO Business Overview
9.6.5 OBiO Recent Developments
9.7 GenScript
9.7.1 GenScript Basic Information
9.7.2 GenScript Gene Cell Therapy CDMO Product Overview
9.7.3 GenScript Gene Cell Therapy CDMO Product Market Performance
9.7.4 GenScript Business Overview
9.7.5 GenScript Recent Developments
9.8 Pharmaron
9.8.1 Pharmaron Basic Information
9.8.2 Pharmaron Gene Cell Therapy CDMO Product Overview
9.8.3 Pharmaron Gene Cell Therapy CDMO Product Market Performance
9.8.4 Pharmaron Business Overview
9.8.5 Pharmaron Recent Developments
9.9 Porton
9.9.1 Porton Basic Information
9.9.2 Porton Gene Cell Therapy CDMO Product Overview
9.9.3 Porton Gene Cell Therapy CDMO Product Market Performance
9.9.4 Porton Business Overview
9.9.5 Porton Recent Developments
9.10 Resilience
9.10.1 Resilience Basic Information
9.10.2 Resilience Gene Cell Therapy CDMO Product Overview
9.10.3 Resilience Gene Cell Therapy CDMO Product Market Performance
9.10.4 Resilience Business Overview
9.10.5 Resilience Recent Developments
9.11 SK Pharmteco
9.11.1 SK Pharmteco Basic Information
9.11.2 SK Pharmteco Gene Cell Therapy CDMO Product Overview
9.11.3 SK Pharmteco Gene Cell Therapy CDMO Product Market Performance
9.11.4 SK Pharmteco Business Overview
9.11.5 SK Pharmteco Recent Developments
9.12 Forge Biologics
9.12.1 Forge Biologics Basic Information
9.12.2 Forge Biologics Gene Cell Therapy CDMO Product Overview
9.12.3 Forge Biologics Gene Cell Therapy CDMO Product Market Performance
9.12.4 Forge Biologics Business Overview
9.12.5 Forge Biologics Recent Developments
9.13 Andelyn Biosciences
9.13.1 Andelyn Biosciences Basic Information
9.13.2 Andelyn Biosciences Gene Cell Therapy CDMO Product Overview
9.13.3 Andelyn Biosciences Gene Cell Therapy CDMO Product Market Performance
9.13.4 Andelyn Biosciences Business Overview
9.13.5 Andelyn Biosciences Recent Developments
9.14 Roslin CT
9.14.1 Roslin CT Basic Information
9.14.2 Roslin CT Gene Cell Therapy CDMO Product Overview
9.14.3 Roslin CT Gene Cell Therapy CDMO Product Market Performance
9.14.4 Roslin CT Business Overview
9.14.5 Roslin CT Recent Developments
9.15 eXmoor Pharma
9.15.1 eXmoor Pharma Basic Information
9.15.2 eXmoor Pharma Gene Cell Therapy CDMO Product Overview
9.15.3 eXmoor Pharma Gene Cell Therapy CDMO Product Market Performance
9.15.4 eXmoor Pharma Business Overview
9.15.5 eXmoor Pharma Recent Developments
9.16 Advanced Therapies
9.16.1 Advanced Therapies Basic Information
9.16.2 Advanced Therapies Gene Cell Therapy CDMO Product Overview
9.16.3 Advanced Therapies Gene Cell Therapy CDMO Product Market Performance
9.16.4 Advanced Therapies Business Overview
9.16.5 Advanced Therapies Recent Developments
9.17 Catalent Biologics
9.17.1 Catalent Biologics Basic Information
9.17.2 Catalent Biologics Gene Cell Therapy CDMO Product Overview
9.17.3 Catalent Biologics Gene Cell Therapy CDMO Product Market Performance
9.17.4 Catalent Biologics Business Overview
9.17.5 Catalent Biologics Recent Developments
9.18 Patheon Pharma Services
9.18.1 Patheon Pharma Services Basic Information
9.18.2 Patheon Pharma Services Gene Cell Therapy CDMO Product Overview
9.18.3 Patheon Pharma Services Gene Cell Therapy CDMO Product Market Performance
9.18.4 Patheon Pharma Services Business Overview
9.18.5 Patheon Pharma Services Recent Developments
10 GENE CELL THERAPY CDMO MARKET FORECAST BY REGION
10.1 Global Gene Cell Therapy CDMO Market Size Forecast
10.2 Global Gene Cell Therapy CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene Cell Therapy CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Gene Cell Therapy CDMO Market Size Forecast by Region
10.2.4 South America Gene Cell Therapy CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Gene Cell Therapy CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Gene Cell Therapy CDMO Market Forecast by Type (2026-2035)
11.1.1 Global Gene Cell Therapy CDMO Market Size Forecast by Type (2026-2035)
11.2 Global Gene Cell Therapy CDMO Market Forecast by Application (2026-2035)
11.2.1 Global Gene Cell Therapy CDMO Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gene Cell Therapy CDMO
1.2 Key Market Segments
1.2.1 Gene Cell Therapy CDMO Segment by Type
1.2.2 Gene Cell Therapy CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE CELL THERAPY CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE CELL THERAPY CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Cell Therapy CDMO Product Life Cycle
3.3 Global Gene Cell Therapy CDMO Revenue Market Share by Company (2020-2025)
3.4 Gene Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Gene Cell Therapy CDMO Market Competitive Situation and Trends
3.6.1 Gene Cell Therapy CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene Cell Therapy CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GENE CELL THERAPY CDMO VALUE CHAIN ANALYSIS
4.1 Gene Cell Therapy CDMO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE CELL THERAPY CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Cell Therapy CDMO Market Porter's Five Forces Analysis
6 GENE CELL THERAPY CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Cell Therapy CDMO Market by Type (2020-2025)
6.3 Global Gene Cell Therapy CDMO Market Size Growth Rate by Type (2021-2025)
7 GENE CELL THERAPY CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Cell Therapy CDMO Market Size (M USD) by Application (2020-2025)
7.3 Global Gene Cell Therapy CDMO Market Size Growth Rate by Application (2021-2025)
8 GENE CELL THERAPY CDMO MARKET SEGMENTATION BY REGION
8.1 Global Gene Cell Therapy CDMO Market Size by Region
8.1.1 Global Gene Cell Therapy CDMO Market Size by Region
8.1.2 Global Gene Cell Therapy CDMO Market Size Market Share by Region
8.2 North America
8.2.1 North America Gene Cell Therapy CDMO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene Cell Therapy CDMO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Gene Cell Therapy CDMO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene Cell Therapy CDMO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene Cell Therapy CDMO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Catalent
9.1.1 Catalent Basic Information
9.1.2 Catalent Gene Cell Therapy CDMO Product Overview
9.1.3 Catalent Gene Cell Therapy CDMO Product Market Performance
9.1.4 Catalent SWOT Analysis
9.1.5 Catalent Business Overview
9.1.6 Catalent Recent Developments
9.2 Lonza
9.2.1 Lonza Basic Information
9.2.2 Lonza Gene Cell Therapy CDMO Product Overview
9.2.3 Lonza Gene Cell Therapy CDMO Product Market Performance
9.2.4 Lonza SWOT Analysis
9.2.5 Lonza Business Overview
9.2.6 Lonza Recent Developments
9.3 Charles River
9.3.1 Charles River Basic Information
9.3.2 Charles River Gene Cell Therapy CDMO Product Overview
9.3.3 Charles River Gene Cell Therapy CDMO Product Market Performance
9.3.4 Charles River SWOT Analysis
9.3.5 Charles River Business Overview
9.3.6 Charles River Recent Developments
9.4 Oxford Biomedica
9.4.1 Oxford Biomedica Basic Information
9.4.2 Oxford Biomedica Gene Cell Therapy CDMO Product Overview
9.4.3 Oxford Biomedica Gene Cell Therapy CDMO Product Market Performance
9.4.4 Oxford Biomedica Business Overview
9.4.5 Oxford Biomedica Recent Developments
9.5 Novartis
9.5.1 Novartis Basic Information
9.5.2 Novartis Gene Cell Therapy CDMO Product Overview
9.5.3 Novartis Gene Cell Therapy CDMO Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 OBiO
9.6.1 OBiO Basic Information
9.6.2 OBiO Gene Cell Therapy CDMO Product Overview
9.6.3 OBiO Gene Cell Therapy CDMO Product Market Performance
9.6.4 OBiO Business Overview
9.6.5 OBiO Recent Developments
9.7 GenScript
9.7.1 GenScript Basic Information
9.7.2 GenScript Gene Cell Therapy CDMO Product Overview
9.7.3 GenScript Gene Cell Therapy CDMO Product Market Performance
9.7.4 GenScript Business Overview
9.7.5 GenScript Recent Developments
9.8 Pharmaron
9.8.1 Pharmaron Basic Information
9.8.2 Pharmaron Gene Cell Therapy CDMO Product Overview
9.8.3 Pharmaron Gene Cell Therapy CDMO Product Market Performance
9.8.4 Pharmaron Business Overview
9.8.5 Pharmaron Recent Developments
9.9 Porton
9.9.1 Porton Basic Information
9.9.2 Porton Gene Cell Therapy CDMO Product Overview
9.9.3 Porton Gene Cell Therapy CDMO Product Market Performance
9.9.4 Porton Business Overview
9.9.5 Porton Recent Developments
9.10 Resilience
9.10.1 Resilience Basic Information
9.10.2 Resilience Gene Cell Therapy CDMO Product Overview
9.10.3 Resilience Gene Cell Therapy CDMO Product Market Performance
9.10.4 Resilience Business Overview
9.10.5 Resilience Recent Developments
9.11 SK Pharmteco
9.11.1 SK Pharmteco Basic Information
9.11.2 SK Pharmteco Gene Cell Therapy CDMO Product Overview
9.11.3 SK Pharmteco Gene Cell Therapy CDMO Product Market Performance
9.11.4 SK Pharmteco Business Overview
9.11.5 SK Pharmteco Recent Developments
9.12 Forge Biologics
9.12.1 Forge Biologics Basic Information
9.12.2 Forge Biologics Gene Cell Therapy CDMO Product Overview
9.12.3 Forge Biologics Gene Cell Therapy CDMO Product Market Performance
9.12.4 Forge Biologics Business Overview
9.12.5 Forge Biologics Recent Developments
9.13 Andelyn Biosciences
9.13.1 Andelyn Biosciences Basic Information
9.13.2 Andelyn Biosciences Gene Cell Therapy CDMO Product Overview
9.13.3 Andelyn Biosciences Gene Cell Therapy CDMO Product Market Performance
9.13.4 Andelyn Biosciences Business Overview
9.13.5 Andelyn Biosciences Recent Developments
9.14 Roslin CT
9.14.1 Roslin CT Basic Information
9.14.2 Roslin CT Gene Cell Therapy CDMO Product Overview
9.14.3 Roslin CT Gene Cell Therapy CDMO Product Market Performance
9.14.4 Roslin CT Business Overview
9.14.5 Roslin CT Recent Developments
9.15 eXmoor Pharma
9.15.1 eXmoor Pharma Basic Information
9.15.2 eXmoor Pharma Gene Cell Therapy CDMO Product Overview
9.15.3 eXmoor Pharma Gene Cell Therapy CDMO Product Market Performance
9.15.4 eXmoor Pharma Business Overview
9.15.5 eXmoor Pharma Recent Developments
9.16 Advanced Therapies
9.16.1 Advanced Therapies Basic Information
9.16.2 Advanced Therapies Gene Cell Therapy CDMO Product Overview
9.16.3 Advanced Therapies Gene Cell Therapy CDMO Product Market Performance
9.16.4 Advanced Therapies Business Overview
9.16.5 Advanced Therapies Recent Developments
9.17 Catalent Biologics
9.17.1 Catalent Biologics Basic Information
9.17.2 Catalent Biologics Gene Cell Therapy CDMO Product Overview
9.17.3 Catalent Biologics Gene Cell Therapy CDMO Product Market Performance
9.17.4 Catalent Biologics Business Overview
9.17.5 Catalent Biologics Recent Developments
9.18 Patheon Pharma Services
9.18.1 Patheon Pharma Services Basic Information
9.18.2 Patheon Pharma Services Gene Cell Therapy CDMO Product Overview
9.18.3 Patheon Pharma Services Gene Cell Therapy CDMO Product Market Performance
9.18.4 Patheon Pharma Services Business Overview
9.18.5 Patheon Pharma Services Recent Developments
10 GENE CELL THERAPY CDMO MARKET FORECAST BY REGION
10.1 Global Gene Cell Therapy CDMO Market Size Forecast
10.2 Global Gene Cell Therapy CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene Cell Therapy CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Gene Cell Therapy CDMO Market Size Forecast by Region
10.2.4 South America Gene Cell Therapy CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Gene Cell Therapy CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Gene Cell Therapy CDMO Market Forecast by Type (2026-2035)
11.1.1 Global Gene Cell Therapy CDMO Market Size Forecast by Type (2026-2035)
11.2 Global Gene Cell Therapy CDMO Market Forecast by Application (2026-2035)
11.2.1 Global Gene Cell Therapy CDMO Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Cell Therapy CDMO Market Size by Type (M USD)
Table 4. Global Gene Cell Therapy CDMO Market Size by Application
Table 5. Gene Cell Therapy CDMO Market Size Comparison by Region (M USD)
Table 6. Global Gene Cell Therapy CDMO Revenue (M USD) by Company (2020-2025)
Table 7. Global Gene Cell Therapy CDMO Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Cell Therapy CDMO as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Gene Cell Therapy CDMO Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Gene Cell Therapy CDMO Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Gene Cell Therapy CDMO Market Size by Type (M USD)
Table 22. Global Gene Cell Therapy CDMO Market Size (M USD) by Type (2020-2025)
Table 23. Global Gene Cell Therapy CDMO Market Share by Type (2020-2025)
Table 24. Global Gene Cell Therapy CDMO Market Size Growth Rate by Type (2021-2025)
Table 25. Global Gene Cell Therapy CDMO Market Size by Application
Table 26. Global Gene Cell Therapy CDMO Market Size by Application (2020-2025) & (M USD)
Table 27. Global Gene Cell Therapy CDMO Market Share by Application (2020-2025)
Table 28. Global Gene Cell Therapy CDMO Market Size Growth Rate by Application (2021-2025)
Table 29. Global Gene Cell Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 30. Global Gene Cell Therapy CDMO Market Size Market Share by Region (2020-2025)
Table 31. North America Gene Cell Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Gene Cell Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Gene Cell Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 34. South America Gene Cell Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Gene Cell Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 36. Catalent Basic Information
Table 37. Catalent Gene Cell Therapy CDMO Product Overview
Table 38. Catalent Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Catalent SWOT Analysis
Table 40. Catalent Business Overview
Table 41. Catalent Recent Developments
Table 42. Lonza Basic Information
Table 43. Lonza Gene Cell Therapy CDMO Product Overview
Table 44. Lonza Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Lonza SWOT Analysis
Table 46. Lonza Business Overview
Table 47. Lonza Recent Developments
Table 48. Charles River Basic Information
Table 49. Charles River Gene Cell Therapy CDMO Product Overview
Table 50. Charles River Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Charles River SWOT Analysis
Table 52. Charles River Business Overview
Table 53. Charles River Recent Developments
Table 54. Oxford Biomedica Basic Information
Table 55. Oxford Biomedica Gene Cell Therapy CDMO Product Overview
Table 56. Oxford Biomedica Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Oxford Biomedica Business Overview
Table 58. Oxford Biomedica Recent Developments
Table 59. Novartis Basic Information
Table 60. Novartis Gene Cell Therapy CDMO Product Overview
Table 61. Novartis Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Novartis Business Overview
Table 63. Novartis Recent Developments
Table 64. OBiO Basic Information
Table 65. OBiO Gene Cell Therapy CDMO Product Overview
Table 66. OBiO Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 67. OBiO Business Overview
Table 68. OBiO Recent Developments
Table 69. GenScript Basic Information
Table 70. GenScript Gene Cell Therapy CDMO Product Overview
Table 71. GenScript Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 72. GenScript Business Overview
Table 73. GenScript Recent Developments
Table 74. Pharmaron Basic Information
Table 75. Pharmaron Gene Cell Therapy CDMO Product Overview
Table 76. Pharmaron Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Pharmaron Business Overview
Table 78. Pharmaron Recent Developments
Table 79. Porton Basic Information
Table 80. Porton Gene Cell Therapy CDMO Product Overview
Table 81. Porton Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Porton Business Overview
Table 83. Porton Recent Developments
Table 84. Resilience Basic Information
Table 85. Resilience Gene Cell Therapy CDMO Product Overview
Table 86. Resilience Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Resilience Business Overview
Table 88. Resilience Recent Developments
Table 89. SK Pharmteco Basic Information
Table 90. SK Pharmteco Gene Cell Therapy CDMO Product Overview
Table 91. SK Pharmteco Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 92. SK Pharmteco Business Overview
Table 93. SK Pharmteco Recent Developments
Table 94. Forge Biologics Basic Information
Table 95. Forge Biologics Gene Cell Therapy CDMO Product Overview
Table 96. Forge Biologics Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Forge Biologics Business Overview
Table 98. Forge Biologics Recent Developments
Table 99. Andelyn Biosciences Basic Information
Table 100. Andelyn Biosciences Gene Cell Therapy CDMO Product Overview
Table 101. Andelyn Biosciences Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Andelyn Biosciences Business Overview
Table 103. Andelyn Biosciences Recent Developments
Table 104. Roslin CT Basic Information
Table 105. Roslin CT Gene Cell Therapy CDMO Product Overview
Table 106. Roslin CT Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Roslin CT Business Overview
Table 108. Roslin CT Recent Developments
Table 109. eXmoor Pharma Basic Information
Table 110. eXmoor Pharma Gene Cell Therapy CDMO Product Overview
Table 111. eXmoor Pharma Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 112. eXmoor Pharma Business Overview
Table 113. eXmoor Pharma Recent Developments
Table 114. Advanced Therapies Basic Information
Table 115. Advanced Therapies Gene Cell Therapy CDMO Product Overview
Table 116. Advanced Therapies Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Advanced Therapies Business Overview
Table 118. Advanced Therapies Recent Developments
Table 119. Catalent Biologics Basic Information
Table 120. Catalent Biologics Gene Cell Therapy CDMO Product Overview
Table 121. Catalent Biologics Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 122. Catalent Biologics Business Overview
Table 123. Catalent Biologics Recent Developments
Table 124. Patheon Pharma Services Basic Information
Table 125. Patheon Pharma Services Gene Cell Therapy CDMO Product Overview
Table 126. Patheon Pharma Services Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Patheon Pharma Services Business Overview
Table 128. Patheon Pharma Services Recent Developments
Table 129. Global Gene Cell Therapy CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 130. North America Gene Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Europe Gene Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Asia Pacific Gene Cell Therapy CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Gene Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Middle East and Africa Gene Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Global Gene Cell Therapy CDMO Market Size Forecast by Type (2026-2035) & (M USD)
Table 136. Global Gene Cell Therapy CDMO Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Cell Therapy CDMO Market Size by Type (M USD)
Table 4. Global Gene Cell Therapy CDMO Market Size by Application
Table 5. Gene Cell Therapy CDMO Market Size Comparison by Region (M USD)
Table 6. Global Gene Cell Therapy CDMO Revenue (M USD) by Company (2020-2025)
Table 7. Global Gene Cell Therapy CDMO Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Cell Therapy CDMO as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Gene Cell Therapy CDMO Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Gene Cell Therapy CDMO Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Gene Cell Therapy CDMO Market Size by Type (M USD)
Table 22. Global Gene Cell Therapy CDMO Market Size (M USD) by Type (2020-2025)
Table 23. Global Gene Cell Therapy CDMO Market Share by Type (2020-2025)
Table 24. Global Gene Cell Therapy CDMO Market Size Growth Rate by Type (2021-2025)
Table 25. Global Gene Cell Therapy CDMO Market Size by Application
Table 26. Global Gene Cell Therapy CDMO Market Size by Application (2020-2025) & (M USD)
Table 27. Global Gene Cell Therapy CDMO Market Share by Application (2020-2025)
Table 28. Global Gene Cell Therapy CDMO Market Size Growth Rate by Application (2021-2025)
Table 29. Global Gene Cell Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 30. Global Gene Cell Therapy CDMO Market Size Market Share by Region (2020-2025)
Table 31. North America Gene Cell Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Gene Cell Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Gene Cell Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 34. South America Gene Cell Therapy CDMO Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Gene Cell Therapy CDMO Market Size by Region (2020-2025) & (M USD)
Table 36. Catalent Basic Information
Table 37. Catalent Gene Cell Therapy CDMO Product Overview
Table 38. Catalent Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Catalent SWOT Analysis
Table 40. Catalent Business Overview
Table 41. Catalent Recent Developments
Table 42. Lonza Basic Information
Table 43. Lonza Gene Cell Therapy CDMO Product Overview
Table 44. Lonza Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Lonza SWOT Analysis
Table 46. Lonza Business Overview
Table 47. Lonza Recent Developments
Table 48. Charles River Basic Information
Table 49. Charles River Gene Cell Therapy CDMO Product Overview
Table 50. Charles River Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Charles River SWOT Analysis
Table 52. Charles River Business Overview
Table 53. Charles River Recent Developments
Table 54. Oxford Biomedica Basic Information
Table 55. Oxford Biomedica Gene Cell Therapy CDMO Product Overview
Table 56. Oxford Biomedica Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Oxford Biomedica Business Overview
Table 58. Oxford Biomedica Recent Developments
Table 59. Novartis Basic Information
Table 60. Novartis Gene Cell Therapy CDMO Product Overview
Table 61. Novartis Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Novartis Business Overview
Table 63. Novartis Recent Developments
Table 64. OBiO Basic Information
Table 65. OBiO Gene Cell Therapy CDMO Product Overview
Table 66. OBiO Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 67. OBiO Business Overview
Table 68. OBiO Recent Developments
Table 69. GenScript Basic Information
Table 70. GenScript Gene Cell Therapy CDMO Product Overview
Table 71. GenScript Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 72. GenScript Business Overview
Table 73. GenScript Recent Developments
Table 74. Pharmaron Basic Information
Table 75. Pharmaron Gene Cell Therapy CDMO Product Overview
Table 76. Pharmaron Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Pharmaron Business Overview
Table 78. Pharmaron Recent Developments
Table 79. Porton Basic Information
Table 80. Porton Gene Cell Therapy CDMO Product Overview
Table 81. Porton Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Porton Business Overview
Table 83. Porton Recent Developments
Table 84. Resilience Basic Information
Table 85. Resilience Gene Cell Therapy CDMO Product Overview
Table 86. Resilience Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Resilience Business Overview
Table 88. Resilience Recent Developments
Table 89. SK Pharmteco Basic Information
Table 90. SK Pharmteco Gene Cell Therapy CDMO Product Overview
Table 91. SK Pharmteco Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 92. SK Pharmteco Business Overview
Table 93. SK Pharmteco Recent Developments
Table 94. Forge Biologics Basic Information
Table 95. Forge Biologics Gene Cell Therapy CDMO Product Overview
Table 96. Forge Biologics Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Forge Biologics Business Overview
Table 98. Forge Biologics Recent Developments
Table 99. Andelyn Biosciences Basic Information
Table 100. Andelyn Biosciences Gene Cell Therapy CDMO Product Overview
Table 101. Andelyn Biosciences Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Andelyn Biosciences Business Overview
Table 103. Andelyn Biosciences Recent Developments
Table 104. Roslin CT Basic Information
Table 105. Roslin CT Gene Cell Therapy CDMO Product Overview
Table 106. Roslin CT Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Roslin CT Business Overview
Table 108. Roslin CT Recent Developments
Table 109. eXmoor Pharma Basic Information
Table 110. eXmoor Pharma Gene Cell Therapy CDMO Product Overview
Table 111. eXmoor Pharma Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 112. eXmoor Pharma Business Overview
Table 113. eXmoor Pharma Recent Developments
Table 114. Advanced Therapies Basic Information
Table 115. Advanced Therapies Gene Cell Therapy CDMO Product Overview
Table 116. Advanced Therapies Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Advanced Therapies Business Overview
Table 118. Advanced Therapies Recent Developments
Table 119. Catalent Biologics Basic Information
Table 120. Catalent Biologics Gene Cell Therapy CDMO Product Overview
Table 121. Catalent Biologics Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 122. Catalent Biologics Business Overview
Table 123. Catalent Biologics Recent Developments
Table 124. Patheon Pharma Services Basic Information
Table 125. Patheon Pharma Services Gene Cell Therapy CDMO Product Overview
Table 126. Patheon Pharma Services Gene Cell Therapy CDMO Revenue (M USD) and Gross Margin (2020-2025)
Table 127. Patheon Pharma Services Business Overview
Table 128. Patheon Pharma Services Recent Developments
Table 129. Global Gene Cell Therapy CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 130. North America Gene Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Europe Gene Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Asia Pacific Gene Cell Therapy CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Gene Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Middle East and Africa Gene Cell Therapy CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Global Gene Cell Therapy CDMO Market Size Forecast by Type (2026-2035) & (M USD)
Table 136. Global Gene Cell Therapy CDMO Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Gene Cell Therapy CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Cell Therapy CDMO Market Size (M USD), 2025-2035
Figure 5. Global Gene Cell Therapy CDMO Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Gene Cell Therapy CDMO Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Gene Cell Therapy CDMO Product Life Cycle
Figure 12. Global Gene Cell Therapy CDMO Revenue Share by Company in 2025
Figure 13. Gene Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Gene Cell Therapy CDMO Revenue in 2025
Figure 15. Value Chain Map of Gene Cell Therapy CDMO
Figure 16. Global Gene Cell Therapy CDMO Market PEST Analysis
Figure 17. Global Gene Cell Therapy CDMO Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Gene Cell Therapy CDMO Market Share by Type
Figure 20. Market Share of Gene Cell Therapy CDMO by Type (2020-2025)
Figure 21. Global Gene Cell Therapy CDMO Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gene Cell Therapy CDMO Market Share by Application
Figure 24. Global Gene Cell Therapy CDMO Market Share by Application (2020-2025)
Figure 25. Global Gene Cell Therapy CDMO Market Share by Application in 2024
Figure 26. Global Gene Cell Therapy CDMO Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Gene Cell Therapy CDMO Market Size Market Share by Region (2020-2025)
Figure 28. North America Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Gene Cell Therapy CDMO Market Size Market Share by Country in 2024
Figure 30. U.S. Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Gene Cell Therapy CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Gene Cell Therapy CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Gene Cell Therapy CDMO Market Share by Country in 2024
Figure 35. Germany Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Gene Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Gene Cell Therapy CDMO Market Size Market Share by Region in 2024
Figure 42. China Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Gene Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 48. South America Gene Cell Therapy CDMO Market Size Market Share by Country in 2024
Figure 49. Brazil Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Gene Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Gene Cell Therapy CDMO Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Gene Cell Therapy CDMO Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Gene Cell Therapy CDMO Market Share Forecast by Type (2026-2035)
Figure 61. Global Gene Cell Therapy CDMO Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Gene Cell Therapy CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Cell Therapy CDMO Market Size (M USD), 2025-2035
Figure 5. Global Gene Cell Therapy CDMO Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Gene Cell Therapy CDMO Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Gene Cell Therapy CDMO Product Life Cycle
Figure 12. Global Gene Cell Therapy CDMO Revenue Share by Company in 2025
Figure 13. Gene Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Gene Cell Therapy CDMO Revenue in 2025
Figure 15. Value Chain Map of Gene Cell Therapy CDMO
Figure 16. Global Gene Cell Therapy CDMO Market PEST Analysis
Figure 17. Global Gene Cell Therapy CDMO Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Gene Cell Therapy CDMO Market Share by Type
Figure 20. Market Share of Gene Cell Therapy CDMO by Type (2020-2025)
Figure 21. Global Gene Cell Therapy CDMO Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gene Cell Therapy CDMO Market Share by Application
Figure 24. Global Gene Cell Therapy CDMO Market Share by Application (2020-2025)
Figure 25. Global Gene Cell Therapy CDMO Market Share by Application in 2024
Figure 26. Global Gene Cell Therapy CDMO Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Gene Cell Therapy CDMO Market Size Market Share by Region (2020-2025)
Figure 28. North America Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Gene Cell Therapy CDMO Market Size Market Share by Country in 2024
Figure 30. U.S. Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Gene Cell Therapy CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Gene Cell Therapy CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Gene Cell Therapy CDMO Market Share by Country in 2024
Figure 35. Germany Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Gene Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Gene Cell Therapy CDMO Market Size Market Share by Region in 2024
Figure 42. China Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Gene Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 48. South America Gene Cell Therapy CDMO Market Size Market Share by Country in 2024
Figure 49. Brazil Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Gene Cell Therapy CDMO Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Gene Cell Therapy CDMO Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Gene Cell Therapy CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Gene Cell Therapy CDMO Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Gene Cell Therapy CDMO Market Share Forecast by Type (2026-2035)
Figure 61. Global Gene Cell Therapy CDMO Market Share Forecast by Application (2026-2035)
